$BNAI
Brand Engagement Network Inc. Stock $bnai

$bnai Overview Financials Valuation SEC Filings Company Website

2024 Q1 Form 10-K Financial Statement

#000119312524083577 Filed on April 01, 2024

Income Statement

Concept	2024 Q1	2023 Q4	2023
Revenue	$49.79K	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$6.481M
YoY Change
% of Gross Profit
Research & Development	$250.7K
YoY Change	12433.55%
% of Gross Profit
Depreciation & Amortization	$117.3K
YoY Change	510.17%
% of Gross Profit
Operating Expenses	$6.849M	$324.2K	$2.810M
YoY Change	2078.22%	-60.67%	-47.87%
Operating Profit	-$6.799M		-$2.810M
YoY Change	2062.39%		-47.87%
Interest Expense	-$21.93K	$492.1K	$4.361M
YoY Change	-100.79%	-81.2%	-2.28%
% of Operating Profit
Other Income/Expense, Net	-$85.65K	-$7.280M	-$4.070M
YoY Change	-103.58%	-591.98%	-132.31%
Pretax Income	-$6.884M	-$7.112M	-$6.880M
YoY Change	-431.29%	-317.28%	-195.47%
Income Tax			$0.00
% Of Pretax Income
Net Earnings	-$6.900M	-$7.112M	-$6.880M
YoY Change	-432.04%	-317.28%	-195.47%
Net Earnings / Revenue	-13858.2%
Basic Earnings Per Share	-$0.27
Diluted Earnings Per Share	-$0.27	-$0.62	-$0.39
COMMON SHARES
Basic Shares Outstanding	33.30M
Diluted Shares Outstanding	25.23M shares

Balance Sheet

Concept	2024 Q1	2023 Q4	2023
SHORT-TERM ASSETS
Cash & Short-Term Investments			$1.685M
YoY Change			692.54%
Cash & Equivalents	$3.304M	$40.17K	$1.685M
Short-Term Investments
Other Short-Term Assets			$201.3K
YoY Change			219.36%
Inventory
Prepaid Expenses
Receivables	$7.500K	$10.00K	$10.00K
Other Receivables	$3.000K	$0.00	$0.00
Total Short-Term Assets	$4.354M	$44.83K	$1.896M
YoY Change	1999.76%	-83.73%	587.97%
LONG-TERM ASSETS
Property, Plant & Equipment	$1.176M	$802.6K	$802.6K
YoY Change
Goodwill
YoY Change
Intangibles	$17.85M	$17.88M
YoY Change
Long-Term Investments
YoY Change
Other Assets	$13.48M	$1.428M	$1.428M
YoY Change	-71.46%	-99.55%	-99.55%
Total Long-Term Assets	$32.50M	$22.06M	$20.11M
YoY Change	-32.44%	-92.97%	-93.59%
TOTAL ASSETS
Total Short-Term Assets	$4.354M	$44.83K	$1.896M
Total Long-Term Assets	$32.50M	$22.06M	$20.11M
Total Assets	$36.85M	$22.10M	$22.01M
YoY Change	-23.72%	-92.97%	-93.0%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.417M	$1.283M	$1.283M
YoY Change	-21.65%	-76.42%	-76.42%
Accrued Expenses	$7.773M	$7.370M	$1.637M
YoY Change		35.46%
Deferred Revenue	$0.00	$2.290K
YoY Change
Short-Term Debt	$223.3K	$223.3K	$223.3K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$13.11M	$8.020M	$3.146M
YoY Change	130.46%	47.4%	-42.19%
LONG-TERM LIABILITIES
Long-Term Debt			$1.169M
YoY Change
Other Long-Term Liabilities			$0.00
YoY Change			-100.0%
Total Long-Term Liabilities			$1.169M
YoY Change			-89.37%
TOTAL LIABILITIES
Total Short-Term Liabilities	$13.11M	$8.020M	$3.146M
Total Long-Term Liabilities			$1.169M
Total Liabilities	$16.25M	$8.782M	$4.314M
YoY Change	-4.78%	-46.57%	-73.75%
SHAREHOLDERS EQUITY
Retained Earnings	-$20.20M	-$12.99M
YoY Change	19.82%	-19.61%
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$20.60M	-$8.737M	$17.69M
YoY Change
Total Liabilities & Shareholders Equity	$36.85M	$22.10M	$22.01M
YoY Change	-23.72%	-92.97%	-93.0%

Cashflow Statement

Concept	2024 Q1	2023 Q4	2023
OPERATING ACTIVITIES
Net Income	-$6.900M	-$7.112M	-$6.880M
YoY Change	-432.04%	-317.28%	-195.47%
Depreciation, Depletion And Amortization	$117.3K
YoY Change	510.17%
Cash From Operating Activities	-$4.500M	-$95.64K	-$822.4K
YoY Change	4018.54%	-30.11%	26.75%
INVESTING ACTIVITIES
Capital Expenditures	$13.04K
YoY Change
Acquisitions
YoY Change
Other Investing Activities	-$158.0K	$27.63M	$296.2M
YoY Change	-100.06%
Cash From Investing Activities	-$171.1K	$27.63M	$296.2M
YoY Change	-100.06%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net			$296.2M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$6.340M	-27.56M	-295.6M
YoY Change	-102.36%
NET CHANGE
Cash From Operating Activities	-$4.500M	-95.64K	-822.4K
Cash From Investing Activities	-$171.1K	27.63M	296.2M
Cash From Financing Activities	$6.340M	-27.56M	-295.6M
Net Change In Cash	$1.619M	-20.64K	-172.4K
YoY Change	-1582.01%	-84.92%	-73.42%
FREE CASH FLOW
Cash From Operating Activities	-$4.500M	-$95.64K	-$822.4K
Capital Expenditures	$13.04K
Free Cash Flow	-$4.513M
YoY Change	4030.47%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001838163
CY2023	dei	Document Type DocumentType	10-K
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity Registrant Name EntityRegistrantName	BRAND ENGAGEMENT NETWORK INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity File Number EntityFileNumber	001-40130
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	98-1574798
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	145 E. Snow King Ave
CY2023	dei	Entity Address Address Line2 EntityAddressAddressLine2	PO Box 104
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Jackson
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	WY
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	83001
CY2023	dei	City Area Code CityAreaCode	214
CY2023	dei	Local Phone Number LocalPhoneNumber	452-2300
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	true
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2023	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	47697082
CY2024Q1	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	33296995
CY2023	dei	Auditor Firm AuditorFirmId	100
CY2023	dei	Auditor Name AuditorName	WithumSmith+Brown, PC
CY2023	dei	Auditor Location AuditorLocation	New York, New York
CY2023	dhcau	Number Of Days After Consummation Of Business Combination Within Which Securities Shall Be Registered With Securities Exchange Commission NumberOfDaysAfterConsummationOfBusinessCombinationWithinWhichSecuritiesShallBeRegisteredWithSecuritiesExchangeCommission	P20D
CY2023Q4	us-gaap	Cash Cash	40167
CY2022Q4	us-gaap	Cash Cash	212608
CY2023Q4	dhcau	Due From Related Party Current DueFromRelatedPartyCurrent	3000
CY2022Q4	dhcau	Due From Related Party Current DueFromRelatedPartyCurrent	1500
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1667
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	61530
CY2023Q4	us-gaap	Assets Current AssetsCurrent	44834
CY2022Q4	us-gaap	Assets Current AssetsCurrent	275638
CY2023Q4	us-gaap	Accounts Receivable Excluding Accrued Interest After Allowance For Credit Loss Noncurrent AccountsReceivableExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent	16824
CY2023Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	22040092
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	313913217
CY2023Q4	us-gaap	Assets Assets	22101750
CY2022Q4	us-gaap	Assets Assets	314188855
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	7370094
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5440933
CY2023Q4	dhcau	Advances From Related Party Current AdvancesFromRelatedPartyCurrent	650000
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8020094
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	5440933
CY2023Q4	dhcau	Warrant Liabilities Non Current WarrantLiabilitiesNonCurrent	328820
CY2022	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	4462497
CY2022Q4	dhcau	Warrant Liabilities Non Current WarrantLiabilitiesNonCurrent	164410
CY2023Q4	dhcau	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable	433231
CY2022Q4	dhcau	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable	10830775
CY2023Q4	us-gaap	Liabilities Liabilities	8782145
CY2022Q4	us-gaap	Liabilities Liabilities	16436118
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies
CY2023Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	22056915
CY2022Q4	us-gaap	Temporary Equity Carrying Amount Attributable To Parent TemporaryEquityCarryingAmountAttributableToParent	313913217
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue	0
CY2023Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4253964
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-12992048
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-16161254
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-8737310
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-16160480
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	22101750
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	314188855
CY2023	dhcau	Operating And Formation Costs OperatingAndFormationCosts	2809965
CY2022	dhcau	Operating And Formation Costs OperatingAndFormationCosts	5390808
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-2809965
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-5390808
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	164410
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-8135024
CY2023	dhcau	Expenses Related To Non Redemption Agreement ExpensesRelatedToNonRedemptionAgreement	8614541
CY2022	dhcau	Expenses Related To Non Redemption Agreement ExpensesRelatedToNonRedemptionAgreement	0
CY2023	dhcau	Deferred Underwriting Fee Decrease Forgiveness DeferredUnderwritingFeeDecreaseForgiveness	-348344
CY2022	dhcau	Deferred Underwriting Fee Decrease Forgiveness DeferredUnderwritingFeeDecreaseForgiveness	0
CY2023	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	4360578
CY2022	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	4462497
CY2023	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4070029
CY2022	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	12597521
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6879994
CY2022	us-gaap	Net Income Loss NetIncomeLoss	7206713
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	-18904696
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	4462497
CY2022	us-gaap	Net Income Loss NetIncomeLoss	7206713
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-16160480
CY2023	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	8614541
CY2023	dhcau	Adjustments To Additional Paid In Capital Reduction Of Deferred Underwriting Fee AdjustmentsToAdditionalPaidInCapitalReductionOfDeferredUnderwritingFee	10049200
CY2023	us-gaap	Temporary Equity Accretion To Redemption Value TemporaryEquityAccretionToRedemptionValue	4360577
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-6879994
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-8737310
CY2023	us-gaap	Profit Loss ProfitLoss	-6879994
CY2022	us-gaap	Profit Loss ProfitLoss	7206713
CY2023	us-gaap	Investment Income Nonoperating InvestmentIncomeNonoperating	4360578
CY2023	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	164410
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-8135024
CY2023	us-gaap	Issuance Of Stock And Warrants For Services Or Claims IssuanceOfStockAndWarrantsForServicesOrClaims	8614541
CY2023	dhcau	Deferred Underwriting Fee Decrease Forgiveness DeferredUnderwritingFeeDecreaseForgiveness	-348344
CY2023	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	1500
CY2022	us-gaap	Increase Decrease In Due From Related Parties Current IncreaseDecreaseInDueFromRelatedPartiesCurrent	1500
CY2023	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-59863
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-327136
CY2023	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	1929161
CY2022	us-gaap	Increase Decrease In Accounts Payable And Accrued Liabilities IncreaseDecreaseInAccountsPayableAndAccruedLiabilities	4416306
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-822441
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-648866
CY2023	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	296233702
CY2022	us-gaap	Proceeds From Sale Of Restricted Investments ProceedsFromSaleOfRestrictedInvestments	0
CY2023	us-gaap	Payments To Acquire Receivables PaymentsToAcquireReceivables	16824
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	296216878
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	0
CY2023	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	650000
CY2022	us-gaap	Proceeds From Related Party Debt ProceedsFromRelatedPartyDebt	0
CY2023	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	296216878
CY2022	us-gaap	Payments For Repurchase Of Common Stock PaymentsForRepurchaseOfCommonStock	0
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-295566878
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-172441
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-648866
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	212608
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	861474
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	40167
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	212608
CY2023	dhcau	Deferred Underwriting Fees Payable DeferredUnderwritingFeesPayable	-10049200
CY2022	dhcau	Deferred Underwriting Fees Payable DeferredUnderwritingFeesPayable	0
CY2023	dei	Entity Incorporation Date Of Incorporation EntityIncorporationDateOfIncorporation	2020-12-22
CY2023Q4	dhcau	Business Combination Consummate Term Period BusinessCombinationConsummateTermPeriod	December 4, 2023 to May 4, 2024
CY2021Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	300000000
CY2023	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	9450720
CY2023Q4	dhcau	Assets Deposited In Trust Noncurrent AssetsDepositedInTrustNoncurrent	309450720
CY2023Q4	dhcau	Transaction Cost TransactionCost	17501346
CY2021Q1	dhcau	Cash Underwriting Fess Net Of Reimbursement CashUnderwritingFessNetOfReimbursement	6189014
CY2023Q4	dhcau	Deferred Underwriting Fee Payable Non Current DeferredUnderwritingFeePayableNonCurrent	10830775
CY2023Q4	dhcau	Other Offering Costs Payable OtherOfferingCostsPayable	481557
CY2023Q1	dhcau	Net Tangible Assets Required For Consummation Of Business Combination NetTangibleAssetsRequiredForConsummationOfBusinessCombination	5000001
CY2023Q3	us-gaap	Minimum Net Worth Required For Compliance MinimumNetWorthRequiredForCompliance	5000001
CY2023Q4	us-gaap	Cash Cash	40167
CY2023Q4	dhcau	Working Capital WorkingCapital	7975260
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	4515979
CY2023Q1	dhcau	Expenses Related To Non Redemption Agreement ExpensesRelatedToNonRedemptionAgreement	7291533
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5213464
CY2023Q1	dhcau	Adjustments To Additional Paid In Capital Shareholder Non Redemption Agreement AdjustmentsToAdditionalPaidInCapitalShareholderNonRedemptionAgreement	0
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Other AdjustmentsToAdditionalPaidInCapitalOther	7291533
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-5213464
CY2023Q1	dhcau	Fair Value Of Founder Shares Assigned In Connection With Non Redemption Agreements FairValueOfFounderSharesAssignedInConnectionWithNonRedemptionAgreements	7291533
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-109262
CY2023Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3996669
CY2023Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-21631053
	dhcau	Expenses Related To Non Redemption Agreement ExpensesRelatedToNonRedemptionAgreement	7291533
	us-gaap	Net Income Loss NetIncomeLoss	-5469799
	us-gaap	Net Income Loss NetIncomeLoss	-5469799
	dhcau	Fair Value Of Founder Shares Assigned In Connection With Non Redemption Agreements FairValueOfFounderSharesAssignedInConnectionWithNonRedemptionAgreements	7291533
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-482314
CY2023Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	3423088
CY2023Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-23220936
	dhcau	Expenses Related To Non Redemption Agreement ExpensesRelatedToNonRedemptionAgreement	7291533
	us-gaap	Net Income Loss NetIncomeLoss	-7059712
	us-gaap	Net Income Loss NetIncomeLoss	-7059712
	dhcau	Fair Value Of Founder Shares Assigned In Connection With Non Redemption Agreements FairValueOfFounderSharesAssignedInConnectionWithNonRedemptionAgreements	7291533
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-726761
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: "Times New Roman";"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Use of Estimates </div></div></div></div><div style="font-family: Times New Roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;;text-indent: 0px;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: "Times New Roman"; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of the consolidated financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. </div></div></div><div style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the consolidated financial statements, which management considered in formulating its estimate, could change in the near term due to <div style="letter-spacing: 0px; top: 0px;;display:inline;">one or more future confirming events</div>. One of the more significant accounting estimates included in these consolidated financial statements is the determination of the fair value of the warrant liability. Such estimates may be subject to change as more current information becomes available and, accordingly, the actual results could differ significantly from those estimates. </div>
CY2023	dhcau	Future Confirming Events FutureConfirmingEvents	one or more future confirming events
CY2023	dhcau	Term Of Short Term Investments TermOfShortTermInvestments	P3M
CY2023Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0
CY2022Q4	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	0
CY2022Q4	us-gaap	Assets Held In Trust Noncurrent AssetsHeldInTrustNoncurrent	313913217
CY2022Q4	us-gaap	Accounts Receivable Excluding Accrued Interest After Allowance For Credit Loss Noncurrent AccountsReceivableExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent	887555
CY2023Q4	us-gaap	Accounts Receivable Excluding Accrued Interest After Allowance For Credit Loss Noncurrent AccountsReceivableExcludingAccruedInterestAfterAllowanceForCreditLossNoncurrent	16824
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top: 18pt; margin-bottom: 0pt; font-size: 10pt; font-family: "Times New Roman";"><div style="font-weight:bold;display:inline;"><div style="font-style: normal; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div></div> <div style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Company has historically had significant cash balances at financial institutions which throughout the year regularly exceed the federally insured limit of $250,000. Any loss incurred or a lack of access to such funds could have a significant adverse impact on the Company’s financial condition, results of operations, and cash flows. </div>
CY2023Q4	us-gaap	Cash Fdic Insured Amount CashFDICInsuredAmount	250000
CY2023	dhcau	Aggregate Offering Costs Incurred AggregateOfferingCostsIncurred	17501347
CY2023	dhcau	Offering Costs Charged To Temporary Equity OfferingCostsChargedToTemporaryEquity	16915008
CY2023	dhcau	Offering Costs Expensed OfferingCostsExpensed	586339
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	0
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0
CY2022	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2023	us-gaap	Weighted Average Number Diluted Shares Outstanding Adjustment WeightedAverageNumberDilutedSharesOutstandingAdjustment	0
CY2023	us-gaap	Payments To Acquire Restricted Investments PaymentsToAcquireRestrictedInvestments	9450720
CY2023Q4	dhcau	Assets Deposited In Trust Noncurrent AssetsDepositedInTrustNoncurrent	309450720
CY2023	dhcau	Number Of Days After The Completion Of The Business Combination Termination Of The Applicable Lockup Period Occurs NumberOfDaysAfterTheCompletionOfTheBusinessCombinationTerminationOfTheApplicableLockupPeriodOccurs	P45D
CY2021Q1	us-gaap	Stock Repurchased And Retired During Period Shares StockRepurchasedAndRetiredDuringPeriodShares	3554928
CY2023Q4	dhcau	Deferred Underwriting Fee Payable Per Unit DeferredUnderwritingFeePayablePerUnit	0.35
CY2023Q4	dhcau	Deferred Underwriting Fee Payable Non Current DeferredUnderwritingFeePayableNonCurrent	10830775
CY2023	dhcau	Deferred Underwriting Fee Forgiven DeferredUnderwritingFeeForgiven	10397544
CY2023	dhcau	Adjustment To Additional Paid In Capital Deferred Underwriting Commission Waived AdjustmentToAdditionalPaidInCapitalDeferredUnderwritingCommissionWaived	10397544
CY2023	dhcau	Gain On Extinguishment Of Underwriting Liability Recognized In Income Statement GainOnExtinguishmentOfUnderwritingLiabilityRecognizedInIncomeStatement	348344
CY2023Q4	dhcau	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable	433231
CY2022Q4	dhcau	Deferred Underwriting Fee Payable DeferredUnderwritingFeePayable	10830775
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0
CY2023	dhcau	Number Of Days After Consummation Of Business Combination Within Which Securities Registration Shall Become Effective NumberOfDaysAfterConsummationOfBusinessCombinationWithinWhichSecuritiesRegistrationShallBecomeEffective	P60D

Files In Submission

Name	View Source	Status
0001193125-24-083577-index-headers.html	Edgar Link	pending
0001193125-24-083577-index.html	Edgar Link	pending
0001193125-24-083577.txt	Edgar Link	pending
0001193125-24-083577-xbrl.zip	Edgar Link	pending
d786732d10k.htm	Edgar Link	pending
d786732dex141.htm	Edgar Link	pending
d786732dex311.htm	Edgar Link	pending
d786732dex312.htm	Edgar Link	pending
d786732dex321.htm	Edgar Link	pending
d786732dex322.htm	Edgar Link	pending
d786732dex971.htm	Edgar Link	pending
dhcau-20231231.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
g786732g10d46.jpg	Edgar Link	pending
g786732g39h22.jpg	Edgar Link	pending
g786732g55o46.jpg	Edgar Link	pending
g786732g97c65.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
dhcau-20231231_cal.xml	Edgar Link	unprocessable
dhcau-20231231_def.xml	Edgar Link	unprocessable
dhcau-20231231_lab.xml	Edgar Link	unprocessable
dhcau-20231231_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
d786732d10k_htm.xml	Edgar Link	completed
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$BNAI
Brand Engagement Network Inc. Stock $bnai

2024 Q1 Form 10-K Financial Statement

#000119312524083577 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BNAI Brand Engagement Network Inc. Stock $bnai

2024 Q1 Form 10-K Financial Statement

#000119312524083577 Filed on April 01, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$BNAI
Brand Engagement Network Inc. Stock $bnai